Agencourt Bioscience Corporation
www.agencourt.com

A wholly owned subsidiary of Beckman Coulter, Inc., is a leading provider of genomic services and nucleic acid purification products in the life sciences market. Their products and services support the advancement of science in understanding biology, improving health and delivering safe and effective treatments for disease. Agencourt's purification products and services are based on the patented Agencourt SPRI® (Solid Phase Reversible Immobilization) technology, which has been adopted by several of the largest genome research facilities and used to sequence over one-third of the human genome. Agencourt was one of five NHGRI-funded Large-Scale Sequencing Centers whose goal was to sequence genomes of organisms of high biomedical importance. The company's state-of-the-art facilities are guided by the FDA's Good Laboratory Practices (GLP) as a contract analytical laboratory. Agencourt is located in Beverly, Massachusetts. For more information go to Agencourt Bioscience.